Peter Hasselbacher

694 total citations
26 papers, 531 citations indexed

About

Peter Hasselbacher is a scholar working on Immunology, Molecular Biology and Nephrology. According to data from OpenAlex, Peter Hasselbacher has authored 26 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Nephrology. Recurrent topics in Peter Hasselbacher's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Complement system in diseases (4 papers) and Cell Adhesion Molecules Research (4 papers). Peter Hasselbacher is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Complement system in diseases (4 papers) and Cell Adhesion Molecules Research (4 papers). Peter Hasselbacher collaborates with scholars based in United States. Peter Hasselbacher's co-authors include E. Carwile LeRoy, H. Ralph Schumacher, Henrik Schumacher, Edward D. Harris, R. M. McMillan, Carol A. Vater, William Firshein, Frank Passero, Allen R. Myers and Constance Brinckerhoff and has published in prestigious journals such as The Lancet, Journal of Allergy and Clinical Immunology and Atherosclerosis.

In The Last Decade

Peter Hasselbacher

25 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Hasselbacher United States 16 167 140 109 105 86 26 531
I. Snapper United States 14 95 0.6× 91 0.7× 106 1.0× 103 1.0× 52 0.6× 47 636
Louis G. Ortega United States 9 104 0.6× 78 0.6× 78 0.7× 120 1.1× 89 1.0× 16 705
K E Holley United States 9 338 2.0× 154 1.1× 77 0.7× 146 1.4× 272 3.2× 9 925
J Tenenbaum Canada 11 286 1.7× 54 0.4× 48 0.4× 247 2.4× 35 0.4× 19 587
J. H. Boss Israel 15 137 0.8× 44 0.3× 96 0.9× 407 3.9× 66 0.8× 103 893
R. M. McIntosh United States 10 50 0.3× 133 0.9× 54 0.5× 28 0.3× 96 1.1× 27 370
Mario Giordano Italy 15 57 0.3× 163 1.2× 87 0.8× 78 0.7× 115 1.3× 61 662
J. DERMOT O'FLYNN Ireland 19 180 1.1× 61 0.4× 91 0.8× 369 3.5× 225 2.6× 47 918
Stephan Regenass Switzerland 19 169 1.0× 78 0.6× 223 2.0× 156 1.5× 324 3.8× 40 1.2k
S Maslan United States 9 95 0.6× 34 0.2× 235 2.2× 57 0.5× 36 0.4× 10 854

Countries citing papers authored by Peter Hasselbacher

Since Specialization
Citations

This map shows the geographic impact of Peter Hasselbacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hasselbacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hasselbacher more than expected).

Fields of papers citing papers by Peter Hasselbacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hasselbacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hasselbacher. The network helps show where Peter Hasselbacher may publish in the future.

Co-authorship network of co-authors of Peter Hasselbacher

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hasselbacher. A scholar is included among the top collaborators of Peter Hasselbacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hasselbacher. Peter Hasselbacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hasselbacher, Peter, Allen R. Myers, & Frank Passero. (1988). SERUM AMYLASE AND MACROAMYLASE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Lara D. Veeken. 27(3). 198–201. 9 indexed citations
3.
Hasselbacher, Peter. (1987). Variation in synovial fluid analysis by hospital laboratories. Arthritis & Rheumatism. 30(6). 637–642. 73 indexed citations
4.
Hasselbacher, Peter. (1982). Stimulation of synovial fibroblasts by calcium oxalate and monosodium urate monohydrate. A mechanism of connective tissue degradation in oxalosis and gout.. PubMed. 100(6). 977–85. 29 indexed citations
5.
Hasselbacher, Peter, et al.. (1982). Interactions of murine macrophages with monosodium urate crystals: stimulation of lysosomal enzyme release and prostaglandin synthesis.. PubMed. 8(4). 555–62. 15 indexed citations
6.
McMillan, R. M., et al.. (1981). Induction of collagenase and prostaglandin synthesis in synovial fibroblasts treated with monosodium urate crystals. Journal of Pharmacy and Pharmacology. 33(1). 382–383. 26 indexed citations
7.
Hasselbacher, Peter, et al.. (1981). Antigen-induced arthritis: an immunohistologic study of articular tissue and synovial fluid using the horseradish peroxidase technique.. PubMed. 7(5). 596–608. 5 indexed citations
8.
Hasselbacher, Peter. (1981). Inhibition of complement by gold sodium thiomalate.. PubMed. 8(1). 57–61. 4 indexed citations
9.
Harris, Edward D., Carol A. Vater, Constance Brinckerhoff, R. M. McMillan, & Peter Hasselbacher. (1981). Patterns of regulation of collagen breakdown in articular cartilage. Seminars in Arthritis and Rheumatism. 11(1). 69–70. 2 indexed citations
10.
Hasselbacher, Peter. (1981). Structure of the Synovial Membrane. Clinics in Rheumatic Diseases. 7(1). 57–69. 17 indexed citations
11.
Hasselbacher, Peter, et al.. (1980). In vitro effects of radiographic contrast media on the complement system. Journal of Allergy and Clinical Immunology. 66(3). 217–222. 18 indexed citations
12.
Hasselbacher, Peter. (1979). C3 Activation by Monosodium Urate Monohydrate and Other Crystalline Material. Arthritis & Rheumatism. 22(6). 571–578. 46 indexed citations
13.
Hasselbacher, Peter. (1979). Binding of immunoglobulin and activation of complement by asbestos fibers. Journal of Allergy and Clinical Immunology. 64(4). 294–298. 29 indexed citations
14.
Hasselbacher, Peter. (1979). Immunoelectrophoretic assay for synovial fluid C3 with correction for synovial fluid globulin. Arthritis & Rheumatism. 22(3). 243–250. 16 indexed citations
15.
Hasselbacher, Peter, et al.. (1978). Sedimentation of leukocytes within the joint space.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 81(2). 54–5. 1 indexed citations
16.
Hasselbacher, Peter & H. Ralph Schumacher. (1978). Synovial fluid eosinophilia following arthrography.. PubMed. 5(2). 173–6. 18 indexed citations
17.
Hasselbacher, Peter & Henrik Schumacher. (1978). Immunoglobulin in Tophi and on the Surface of Monosodium Urate Crystals. Arthritis & Rheumatism. 21(3). 353–361. 28 indexed citations
18.
Hasselbacher, Peter, et al.. (1975). JOINT INFECTION BY PASTEURELLA MULTOCIDA. The Lancet. 306(7931). 409–409. 20 indexed citations
19.
Hasselbacher, Peter & E. Carwile LeRoy. (1974). Serum DNA binding activity in healthy subjects and in rheumatic disease. Arthritis & Rheumatism. 17(1). 63–71. 62 indexed citations
20.
Firshein, William & Peter Hasselbacher. (1970). Utilization of deoxyribonucleosides by virulent and avirulent pneumococci. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 204(1). 60–81. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026